1. Home
  2. RNAZ vs FEBO Comparison

RNAZ vs FEBO Comparison

Compare RNAZ & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • FEBO
  • Stock Information
  • Founded
  • RNAZ 2016
  • FEBO 1993
  • Country
  • RNAZ United States
  • FEBO Hong Kong
  • Employees
  • RNAZ N/A
  • FEBO N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • FEBO
  • Sector
  • RNAZ Health Care
  • FEBO
  • Exchange
  • RNAZ Nasdaq
  • FEBO Nasdaq
  • Market Cap
  • RNAZ 8.7M
  • FEBO 8.3M
  • IPO Year
  • RNAZ 2021
  • FEBO 2023
  • Fundamental
  • Price
  • RNAZ $13.77
  • FEBO $0.80
  • Analyst Decision
  • RNAZ Strong Buy
  • FEBO
  • Analyst Count
  • RNAZ 1
  • FEBO 0
  • Target Price
  • RNAZ $280.00
  • FEBO N/A
  • AVG Volume (30 Days)
  • RNAZ 421.5K
  • FEBO 31.1K
  • Earning Date
  • RNAZ 11-13-2025
  • FEBO 11-07-2025
  • Dividend Yield
  • RNAZ N/A
  • FEBO N/A
  • EPS Growth
  • RNAZ N/A
  • FEBO N/A
  • EPS
  • RNAZ N/A
  • FEBO N/A
  • Revenue
  • RNAZ N/A
  • FEBO $17,110,653.00
  • Revenue This Year
  • RNAZ N/A
  • FEBO N/A
  • Revenue Next Year
  • RNAZ N/A
  • FEBO N/A
  • P/E Ratio
  • RNAZ N/A
  • FEBO N/A
  • Revenue Growth
  • RNAZ N/A
  • FEBO 11.58
  • 52 Week Low
  • RNAZ $6.15
  • FEBO $0.61
  • 52 Week High
  • RNAZ $643.94
  • FEBO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 55.86
  • FEBO 56.77
  • Support Level
  • RNAZ $12.11
  • FEBO $0.72
  • Resistance Level
  • RNAZ $15.49
  • FEBO $0.81
  • Average True Range (ATR)
  • RNAZ 1.74
  • FEBO 0.05
  • MACD
  • RNAZ -0.13
  • FEBO 0.01
  • Stochastic Oscillator
  • RNAZ 23.76
  • FEBO 95.61

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: